T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
J. Gotz, F. Chen, R. Barmettler, and R. M. Nitsch, “Tau filament formation in transgenic mice expressing P301L tau,” J. Biol. Chem. 276(1), 529–534 (2001).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
F. Lassailly, K. Foster, L. Lopez-Onieva, E. Currie, and D. Bonnet, “Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells,” Blood 122(10), 1730–1740 (2013).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
V. L. Villemagne, V. Dore, S. C. Burnham, C. L. Masters, and C. C. Rowe, “Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions,” Nat. Rev. Neurol. 14(4), 225–236 (2018).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch, “Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils,” Science 293(5534), 1491–1495 (2001).
[Crossref]
J. Gotz, F. Chen, R. Barmettler, and R. M. Nitsch, “Tau filament formation in transgenic mice expressing P301L tau,” J. Biol. Chem. 276(1), 529–534 (2001).
[Crossref]
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
E. E. Congdon and E. M. Sigurdsson, “Tau-targeting therapies for Alzheimer disease,” Nat. Rev. Neurol. 14(7), 399–415 (2018).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
F. Lassailly, K. Foster, L. Lopez-Onieva, E. Currie, and D. Bonnet, “Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells,” Blood 122(10), 1730–1740 (2013).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
A. Velasco, G. Fraser, P. Delobel, B. Ghetti, I. Lavenir, and M. Goedert, “Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene],” FEBS Lett. 582(6), 901–906 (2008).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
V. L. Villemagne, V. Dore, S. C. Burnham, C. L. Masters, and C. C. Rowe, “Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions,” Nat. Rev. Neurol. 14(4), 225–236 (2018).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
I. Gregor and J. Enderlein, “Image scanning microscopy,” Curr. Opin. Chem. Biol. 51, 74–83 (2019).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
F. Lassailly, K. Foster, L. Lopez-Onieva, E. Currie, and D. Bonnet, “Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells,” Blood 122(10), 1730–1740 (2013).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
A. Velasco, G. Fraser, P. Delobel, B. Ghetti, I. Lavenir, and M. Goedert, “Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene],” FEBS Lett. 582(6), 901–906 (2008).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
I. B. Mazo, J.-C. Gutierrez-Ramos, P. S. Frenette, R. O. Hynes, D. D. Wagner, and U. H. von Andrian, “Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1,” J. Exp. Med. 188(3), 465–474 (1998).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
A. Velasco, G. Fraser, P. Delobel, B. Ghetti, I. Lavenir, and M. Goedert, “Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene],” FEBS Lett. 582(6), 901–906 (2008).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
M. G. Spillantini and M. Goedert, “Tau pathology and neurodegeneration,” Lancet Neurol. 12(6), 609–622 (2013).
[Crossref]
A. Velasco, G. Fraser, P. Delobel, B. Ghetti, I. Lavenir, and M. Goedert, “Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene],” FEBS Lett. 582(6), 901–906 (2008).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
V. M. Lee, M. Goedert, and J. Q. Trojanowski, “Neurodegenerative tauopathies,” Annu. Rev. Neurosci. 24(1), 1121–1159 (2001).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
J. Gotz, F. Chen, R. Barmettler, and R. M. Nitsch, “Tau filament formation in transgenic mice expressing P301L tau,” J. Biol. Chem. 276(1), 529–534 (2001).
[Crossref]
J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch, “Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils,” Science 293(5534), 1491–1495 (2001).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
I. Gregor and J. Enderlein, “Image scanning microscopy,” Curr. Opin. Chem. Biol. 51, 74–83 (2019).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
Q. Wu, Y. Lin, J. Gu, and E. M. Sigurdsson, “Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging,” EBioMedicine 35, 270–278 (2018).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
I. B. Mazo, J.-C. Gutierrez-Ramos, P. S. Frenette, R. O. Hynes, D. D. Wagner, and U. H. von Andrian, “Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1,” J. Exp. Med. 188(3), 465–474 (1998).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
I. B. Mazo, J.-C. Gutierrez-Ramos, P. S. Frenette, R. O. Hynes, D. D. Wagner, and U. H. von Andrian, “Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1,” J. Exp. Med. 188(3), 465–474 (1998).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
P. Verwilst, H. S. Kim, S. Kim, C. Kang, and J. S. Kim, “Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores,” Chem. Soc. Rev. 47(7), 2249–2265 (2018).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
P. Verwilst, H. S. Kim, S. Kim, C. Kang, and J. S. Kim, “Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores,” Chem. Soc. Rev. 47(7), 2249–2265 (2018).
[Crossref]
P. Verwilst, H. S. Kim, S. Kim, C. Kang, and J. S. Kim, “Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores,” Chem. Soc. Rev. 47(7), 2249–2265 (2018).
[Crossref]
P. Verwilst, H. S. Kim, S. Kim, C. Kang, and J. S. Kim, “Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores,” Chem. Soc. Rev. 47(7), 2249–2265 (2018).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
R. Ni, M. Vaas, W. Ren, and J. Klohs, “Non-invasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography,” Neurophotonics 5(1), 015005 (2018).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
J. Klohs, “An Integrated View on Vascular Dysfunction in Alzheimer’s Disease,” Neurodegenerative Diseases (2020).
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
S. Krishnaswamy, Y. Lin, W. J. Rajamohamedsait, H. B. Rajamohamedsait, P. Krishnamurthy, and E. M. Sigurdsson, “Antibody-derived in vivo imaging of tau pathology,” J. Neuroscience 34(50), 16835–16850 (2014).
[Crossref]
S. Krishnaswamy, Y. Lin, W. J. Rajamohamedsait, H. B. Rajamohamedsait, P. Krishnamurthy, and E. M. Sigurdsson, “Antibody-derived in vivo imaging of tau pathology,” J. Neuroscience 34(50), 16835–16850 (2014).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
F. Lassailly, K. Foster, L. Lopez-Onieva, E. Currie, and D. Bonnet, “Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells,” Blood 122(10), 1730–1740 (2013).
[Crossref]
A. Velasco, G. Fraser, P. Delobel, B. Ghetti, I. Lavenir, and M. Goedert, “Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene],” FEBS Lett. 582(6), 901–906 (2008).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
V. M. Lee, M. Goedert, and J. Q. Trojanowski, “Neurodegenerative tauopathies,” Annu. Rev. Neurosci. 24(1), 1121–1159 (2001).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
Q. Wu, Y. Lin, J. Gu, and E. M. Sigurdsson, “Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging,” EBioMedicine 35, 270–278 (2018).
[Crossref]
S. Krishnaswamy, Y. Lin, W. J. Rajamohamedsait, H. B. Rajamohamedsait, P. Krishnamurthy, and E. M. Sigurdsson, “Antibody-derived in vivo imaging of tau pathology,” J. Neuroscience 34(50), 16835–16850 (2014).
[Crossref]
H. Shirani, M. Linares, C. J. Sigurdson, M. Lindgren, P. Norman, and K. P. Nilsson, “A Palette of Fluorescent Thiophene-Based Ligands for the Identification of Protein Aggregates,” Chem. Eur. J. 21(43), 15133–15137 (2015).
[Crossref]
H. Shirani, M. Linares, C. J. Sigurdson, M. Lindgren, P. Norman, and K. P. Nilsson, “A Palette of Fluorescent Thiophene-Based Ligands for the Identification of Protein Aggregates,” Chem. Eur. J. 21(43), 15133–15137 (2015).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
F. Lassailly, K. Foster, L. Lopez-Onieva, E. Currie, and D. Bonnet, “Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells,” Blood 122(10), 1730–1740 (2013).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
V. L. Villemagne, V. Dore, S. C. Burnham, C. L. Masters, and C. C. Rowe, “Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions,” Nat. Rev. Neurol. 14(4), 225–236 (2018).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
I. B. Mazo, J.-C. Gutierrez-Ramos, P. S. Frenette, R. O. Hynes, D. D. Wagner, and U. H. von Andrian, “Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1,” J. Exp. Med. 188(3), 465–474 (1998).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
R. Ni, M. Vaas, W. Ren, and J. Klohs, “Non-invasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography,” Neurophotonics 5(1), 015005 (2018).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
H. Shirani, M. Linares, C. J. Sigurdson, M. Lindgren, P. Norman, and K. P. Nilsson, “A Palette of Fluorescent Thiophene-Based Ligands for the Identification of Protein Aggregates,” Chem. Eur. J. 21(43), 15133–15137 (2015).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
J. Gotz, F. Chen, R. Barmettler, and R. M. Nitsch, “Tau filament formation in transgenic mice expressing P301L tau,” J. Biol. Chem. 276(1), 529–534 (2001).
[Crossref]
J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch, “Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils,” Science 293(5534), 1491–1495 (2001).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
H. Shirani, M. Linares, C. J. Sigurdson, M. Lindgren, P. Norman, and K. P. Nilsson, “A Palette of Fluorescent Thiophene-Based Ligands for the Identification of Protein Aggregates,” Chem. Eur. J. 21(43), 15133–15137 (2015).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
P. Marinkovic, S. Blumenstock, P. M. Goltstein, V. Korzhova, F. Peters, A. Knebl, and J. Herms, “In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model,” Brain 142(4), 1051–1062 (2019).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
S. Krishnaswamy, Y. Lin, W. J. Rajamohamedsait, H. B. Rajamohamedsait, P. Krishnamurthy, and E. M. Sigurdsson, “Antibody-derived in vivo imaging of tau pathology,” J. Neuroscience 34(50), 16835–16850 (2014).
[Crossref]
S. Krishnaswamy, Y. Lin, W. J. Rajamohamedsait, H. B. Rajamohamedsait, P. Krishnamurthy, and E. M. Sigurdsson, “Antibody-derived in vivo imaging of tau pathology,” J. Neuroscience 34(50), 16835–16850 (2014).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
R. Ni, M. Vaas, W. Ren, and J. Klohs, “Non-invasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography,” Neurophotonics 5(1), 015005 (2018).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
V. L. Villemagne, V. Dore, S. C. Burnham, C. L. Masters, and C. C. Rowe, “Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions,” Nat. Rev. Neurol. 14(4), 225–236 (2018).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
A. W. P. Fitzpatrick, B. Falcon, S. He, A. G. Murzin, G. Murshudov, H. J. Garringer, R. A. Crowther, B. Ghetti, M. Goedert, and S. H. W. Scheres, “Cryo-EM structures of tau filaments from Alzheimer's disease,” Nature 547(7662), 185–190 (2017).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
M. Colin, S. Dujardin, S. Schraen-Maschke, G. Meno-Tetang, C. Duyckaerts, J. P. Courade, and L. Buee, “From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,” Acta Neuropathol. 139(1), 3–25 (2020).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
J. A. Gerez, N. C. Prymaczok, E. Rockenstein, U. S. Herrmann, P. Schwarz, A. Adame, R. I. Enchev, T. Courtheoux, P. J. Boersema, R. Riek, M. Peter, A. Aguzzi, E. Masliah, and P. Picotti, “A cullin-RING ubiquitin ligase targets exogenous alpha-synuclein and inhibits Lewy body-like pathology,” Sci. Transl. Med. 11(495), eaau6722 (2019).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
H. Shirani, M. Linares, C. J. Sigurdson, M. Lindgren, P. Norman, and K. P. Nilsson, “A Palette of Fluorescent Thiophene-Based Ligands for the Identification of Protein Aggregates,” Chem. Eur. J. 21(43), 15133–15137 (2015).
[Crossref]
S. Gottschalk, O. Degtyaruk, B. Mc Larney, J. Rebling, M. A. Hutter, X. L. Deán-Ben, S. Shoham, and D. Razansky, “Rapid volumetric optoacoustic imaging of neural dynamics across the mouse brain,” Nat. Biomed. Eng. 3(5), 392–401 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
H. Shirani, M. Linares, C. J. Sigurdson, M. Lindgren, P. Norman, and K. P. Nilsson, “A Palette of Fluorescent Thiophene-Based Ligands for the Identification of Protein Aggregates,” Chem. Eur. J. 21(43), 15133–15137 (2015).
[Crossref]
A. Aslund, C. J. Sigurdson, T. Klingstedt, S. Grathwohl, T. Bolmont, D. L. Dickstein, E. Glimsdal, S. Prokop, M. Lindgren, P. Konradsson, D. M. Holtzman, P. R. Hof, F. L. Heppner, S. Gandy, M. Jucker, A. Aguzzi, P. Hammarström, and K. P. Nilsson, “Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses,” ACS Chem. Biol. 4(8), 673–684 (2009).
[Crossref]
Q. Wu, Y. Lin, J. Gu, and E. M. Sigurdsson, “Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging,” EBioMedicine 35, 270–278 (2018).
[Crossref]
E. E. Congdon and E. M. Sigurdsson, “Tau-targeting therapies for Alzheimer disease,” Nat. Rev. Neurol. 14(7), 399–415 (2018).
[Crossref]
S. Krishnaswamy, Y. Lin, W. J. Rajamohamedsait, H. B. Rajamohamedsait, P. Krishnamurthy, and E. M. Sigurdsson, “Antibody-derived in vivo imaging of tau pathology,” J. Neuroscience 34(50), 16835–16850 (2014).
[Crossref]
T. Klingstedt, A. Aslund, R. A. Simon, L. B. Johansson, J. J. Mason, S. Nystrom, P. Hammarstrom, and K. P. Nilsson, “Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates,” Org. Biomol. Chem. 9(24), 8356–8370 (2011).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
M. Calvo-Rodriguez, S. S. Hou, A. C. Snyder, S. Dujardin, H. Shirani, K. P. R. Nilsson, and B. J. Bacskai, “In vivo detection of tau fibrils and amyloid beta aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy,” Acta Neuropathol. Commun. 7(1), 171 (2019).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
B. J. Hanseeuw, R. A. Betensky, H. I. L. Jacobs, A. P. Schultz, J. Sepulcre, J. A. Becker, D. M. O. Cosio, M. Farrell, Y. T. Quiroz, E. C. Mormino, R. F. Buckley, K. V. Papp, R. A. Amariglio, I. Dewachter, A. Ivanoiu, W. Huijbers, T. Hedden, G. A. Marshall, J. P. Chhatwal, D. M. Rentz, R. A. Sperling, and K. Johnson, “Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study,” JAMA Neurol. 76(8), 915–924 (2019).
[Crossref]
M. G. Spillantini and M. Goedert, “Tau pathology and neurodegeneration,” Lancet Neurol. 12(6), 609–622 (2013).
[Crossref]
P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M. G. Spillantini, R. A. Crowther, and M. Goedert, “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” Am. J. Pathology 172(1), 123–131 (2008).
[Crossref]
E. J. Kim, J. L. Hwang, S. E. Gaus, A. L. Nana, J. Deng, J. A. Brown, S. Spina, M. J. Lee, E. M. Ramos, L. T. Grinberg, J. H. Kramer, A. L. Boxer, M. L. Gorno-Tempini, H. J. Rosen, B. L. Miller, and W. W. Seeley, “Evidence of corticofugal tau spreading in patients with frontotemporal dementia,” Acta Neuropathol. 139(1), 27–43 (2020).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
A. de Calignon, L. M. Fox, R. Pitstick, G. A. Carlson, B. J. Bacskai, T. L. Spires-Jones, and B. T. Hyman, “Caspase activation precedes and leads to tangles,” Nature 464(7292), 1201–1204 (2010).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
S. Hashimoto, Y. Matsuba, N. Kamano, N. Mihira, N. Sahara, J. Takano, S. I. Muramatsu, T. C. Saido, and T. Saito, “Tau binding protein CAPON induces tau aggregation and neurodegeneration,” Nat. Commun. 10(1), 2394 (2019).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
N. Sahara, M. Shimojo, M. Ono, H. Takuwa, M. Febo, M. Higuchi, and T. Suhara, “In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line,” Front Neurol. 8, 663 (2017).
[Crossref]
A. Mueller, S. Bullich, O. Barret, J. Madonia, M. Berndt, C. Papin, A. Perrotin, N. Koglin, H. Kroth, A. Pfeifer, G. Tamagnan, J. P. Seibyl, K. Marek, S. de Santi, L. M. Dinkelborg, and A. W. Stephens, “Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study,” J. Nucl. Med. 61(6), 911–919 (2020).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
V. M. Lee, M. Goedert, and J. Q. Trojanowski, “Neurodegenerative tauopathies,” Annu. Rev. Neurosci. 24(1), 1121–1159 (2001).
[Crossref]
C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, J. Sarmiento, J. Troncoso, G. R. Jackson, and R. Kayed, “Identification of oligomers at early stages of tau aggregation in Alzheimer's disease,” FASEB J. 26(5), 1946–1959 (2012).
[Crossref]
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
R. Ni, M. Vaas, W. Ren, and J. Klohs, “Non-invasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography,” Neurophotonics 5(1), 015005 (2018).
[Crossref]
J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch, “Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils,” Science 293(5534), 1491–1495 (2001).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
S. K. Kaufman, D. W. Sanders, T. L. Thomas, A. J. Ruchinskas, J. Vaquer-Alicea, A. M. Sharma, T. M. Miller, and M. I. Diamond, “Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo,” Neuron 92(4), 796–812 (2016).
[Crossref]
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
A. Velasco, G. Fraser, P. Delobel, B. Ghetti, I. Lavenir, and M. Goedert, “Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene],” FEBS Lett. 582(6), 901–906 (2008).
[Crossref]
P. Verwilst, H. S. Kim, S. Kim, C. Kang, and J. S. Kim, “Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores,” Chem. Soc. Rev. 47(7), 2249–2265 (2018).
[Crossref]
V. L. Villemagne, V. Dore, S. C. Burnham, C. L. Masters, and C. C. Rowe, “Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions,” Nat. Rev. Neurol. 14(4), 225–236 (2018).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
R. La Joie, A. V. Visani, S. L. Baker, J. A. Brown, V. Bourakova, J. Cha, K. Chaudhary, L. Edwards, L. Iaccarino, M. Janabi, O. H. Lesman-Segev, Z. A. Miller, D. C. Perry, J. P. O’Neil, J. Pham, J. C. Rojas, H. J. Rosen, W. W. Seeley, R. M. Tsai, B. L. Miller, W. J. Jagust, and G. D. Rabinovici, “Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET,” Sci. Transl. Med. 12(524), eaau5732 (2020).
[Crossref]
M. Scholl, S. N. Lockhart, D. R. Schonhaut, J. P. O’Neil, M. Janabi, R. Ossenkoppele, S. L. Baker, J. W. Vogel, J. Faria, H. D. Schwimmer, G. D. Rabinovici, and W. J. Jagust, “PET Imaging of Tau Deposition in the Aging Human Brain,” Neuron 89(5), 971–982 (2016).
[Crossref]
R. Ni, X. L. Dean-Ben, D. Kirschenbaum, M. Rudin, Z. Chen, A. Crimi, F. Voigt, P. R. Nilsson, F. Helmchen, R. M. Nitsch, A. Aguzzi, D. Razansky, and J. Klohs, “Whole brain optoacoustic tomography reveals strain-specific regional beta-amyloid densities in Alzheimer`s disease amyloidosis models,” bioRxiv, DOI: 10.1101/2020.1102.1125.964064 (2020).
H. Kroth, F. Oden, J. Molette, H. Schieferstein, F. Capotosti, A. Mueller, M. Berndt, H. Schmitt-Willich, V. Darmency, E. Gabellieri, C. Boudou, T. Juergens, Y. Varisco, E. Vokali, D. T. Hickman, G. Tamagnan, A. Pfeifer, L. Dinkelborg, A. Muhs, and A. Stephens, “Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2178–2189 (2019).
[Crossref]
I. B. Mazo, J.-C. Gutierrez-Ramos, P. S. Frenette, R. O. Hynes, D. D. Wagner, and U. H. von Andrian, “Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1,” J. Exp. Med. 188(3), 465–474 (1998).
[Crossref]
I. B. Mazo, J.-C. Gutierrez-Ramos, P. S. Frenette, R. O. Hynes, D. D. Wagner, and U. H. von Andrian, “Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1,” J. Exp. Med. 188(3), 465–474 (1998).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
B. M. Burmann, J. A. Gerez, I. Matecko-Burmann, S. Campioni, P. Kumari, D. Ghosh, A. Mazur, E. E. Aspholm, D. Sulskis, M. Wawrzyniuk, T. Bock, A. Schmidt, S. G. D. Rudiger, R. Riek, and S. Hiller, “Regulation of alpha-synuclein by chaperones in mammalian cells,” Nature 577(7788), 127–132 (2020).
[Crossref]
B. Wegenast-Braun, A. Skodras, G. Bayraktar, J. Mahler, S. Fritschi, T. Klingstedt, J. Mason, P. Hammarström, K. Nilsson, C. Liebig, and M. Jucker, “Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes,” Am. J. Pathology 181(6), 1953–1960 (2012).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
K. V. Kuchibhotla, S. Wegmann, K. J. Kopeikina, J. Hawkes, N. Rudinskiy, M. L. Andermann, T. L. Spires-Jones, B. J. Bacskai, and B. T. Hyman, “Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo,” Proc. Natl. Acad. Sci. 111(1), 510–514 (2014).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
P. Füger, J. K. Hefendehl, K. Veeraraghavalu, A.-C. Wendeln, C. Schlosser, U. Obermüller, B. M. Wegenast-Braun, J. J. Neher, P. Martus, S. Kohsaka, M. Thunemann, R. Feil, S. S. Sisodia, A. Skodras, and M. Jucker, “Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging,” Nat. Neurosci. 20(10), 1371–1376 (2017).
[Crossref]
C. H. Lo, C. K. Lim, Z. Ding, S. P. Wickramasinghe, A. R. Braun, K. H. Ashe, E. Rhoades, D. D. Thomas, and J. N. Sachs, “Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies,” Alzheimer’s & Dementia 15(11), 1489–1502 (2019).
[Crossref]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23(5), 577–583 (2005).
[Crossref]
S. Sanabria Bohorquez, J. Marik, A. Ogasawara, J. N. Tinianow, H. S. Gill, O. Barret, G. Tamagnan, D. Alagille, G. Ayalon, P. Manser, T. Bengtsson, M. Ward, S. P. Williams, G. A. Kerchner, J. P. Seibyl, K. Marek, and R. M. Weimer, “[(18)F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease,” Eur. J. Nucl. Med. Mol. Imaging 46(10), 2077–2089 (2019).
[Crossref]
K. M. Schoch, S. L. DeVos, R. L. Miller, S. J. Chun, M. Norrbom, D. F. Wozniak, H. N. Dawson, C. F. Bennett, F. Rigo, and T. M. Miller, “Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model,” Neuron 90(5), 941–947 (2016).
[Crossref]
Q. Wu, Y. Lin, J. Gu, and E. M. Sigurdsson, “Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging,” EBioMedicine 35, 270–278 (2018).
[Crossref]
B. Dejanovic, M. A. Huntley, A. De Maziere, W. J. Meilandt, T. Wu, K. Srinivasan, Z. Jiang, V. Gandham, B. A. Friedman, H. Ngu, O. Foreman, R. A. D. Carano, B. Chih, J. Klumperman, C. Bakalarski, J. E. Hanson, and M. Sheng, “Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies,” Neuron 100(6), 1322–1336.e7 (2018).
[Crossref]
J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, G. Royl, D. Megow, U. Dirnagl, J. Priller, and A. Wunder, “In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia,” J. Cereb. Blood Flow Metab. 29(7), 1284–1292 (2009).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
T. K. Patel, L. Habimana-Griffin, X. Gao, B. Xu, S. Achilefu, K. Alitalo, C. A. McKee, P. W. Sheehan, E. S. Musiek, C. Xiong, D. Coble, and D. M. Holtzman, “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol. Neurodegener. 14(1), 11 (2019).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
K. A. Johnson, A. Schultz, R. A. Betensky, J. A. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, J. Alverio, K. Judge, M. Philiossaint, T. Shoup, D. Yokell, B. Dickerson, T. Gomez-Isla, B. Hyman, N. Vasdev, and R. Sperling, “Tau positron emission tomographic imaging in aging and early Alzheimer disease,” Ann Neurol. 79(1), 110–119 (2016).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W. L. Lin, S. H. Yen, D. W. Dickson, P. Davies, and M. Hutton, “Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein,” Nat. Genet. 25(4), 402–405 (2000).
[Crossref]
K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe, “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function,” Science 309(5733), 476–481 (2005).
[Crossref]
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
R. Ni, Y. Zarb, G. A. Kuhn, R. Müller, Y. Yundung, R. M. Nitsch, L. Kulic, A. Keller, and J. Klohs, “Tau deposition is associated with imaging patterns of tissue calcification in the P301L mouse model of human tauopathy,” bioRxiv, 851915 (2019).
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
Z. He, J. D. McBride, H. Xu, L. Changolkar, S. J. Kim, B. Zhang, S. Narasimhan, G. S. Gibbons, J. L. Guo, M. Kozak, G. D. Schellenberg, J. Q. Trojanowski, and V. M. Lee, “Transmission of tauopathy strains is independent of their isoform composition,” Nat. Commun. 11(1), 7 (2020).
[Crossref]
Y. Yoshiyama, M. Higuchi, B. Zhang, S. M. Huang, N. Iwata, T. C. Saido, J. Maeda, T. Suhara, J. Q. Trojanowski, and V. M. Lee, “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron 53(3), 337–351 (2007).
[Crossref]
Y. Zhang, C. Zhang, X. Zhong, and D. Zhu, “Quantitative evaluation of SOCS-induced optical clearing efficiency of skull,” Quant. Imaging Med. Surg. 5, 136–142 (2015).
[Crossref]
R. Ni, B. Ji, M. Ono, N. Sahara, M. R. Zhang, I. Aoki, A. Nordberg, T. Suhara, and M. Higuchi, ““Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models,” Journal of nuclear medicine : official publication,” J. Nucl. Med. 59(6), 960–966 (2018).
[Crossref]
A. Ishikawa, M. Tokunaga, J. Maeda, T. Minamihisamatsu, M. Shimojo, H. Takuwa, M. Ono, R. Ni, S. Hirano, S. Kuwabara, B. Ji, M. R. Zhang, I. Aoki, T. Suhara, M. Higuchi, and N. Sahara, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510,” J. Alzheimer’s Dis. 61(3), 1037–1052 (2018).
[Crossref]
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M. R. Zhang, J. Q. Trojanowski, V. M. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M. K. Jang, I. Aoki, H. Ito, and M. Higuchi, “Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls,” Neuron 79(6), 1094–1108 (2013).
[Crossref]
M. Ono, N. Sahara, K. Kumata, B. Ji, R. Ni, S. Koga, D. W. Dickson, J. Q. Trojanowski, V. M.-Y. Lee, M. Yoshida, I. Hozumi, Y. Yoshiyama, J. C. v. Swieten, A. Nordberg, T. Suhara, M.-R. Zhang, and M. Higuchi, “Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies,” Brain 140, aww339 (2017).
[Crossref]
E. D. Hostetler, A. M. Walji, Z. Zeng, P. Miller, I. Bennacef, C. Salinas, B. Connolly, L. Gantert, H. Haley, M. Holahan, M. Purcell, K. Riffel, T. G. Lohith, P. Coleman, A. Soriano, A. Ogawa, S. Xu, X. Zhang, E. Joshi, J. Della Rocca, D. Hesk, D. J. Schenk, and J. L. Evelhoch, ““Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles,” Journal of nuclear medicine : official publication,” J. Nuclear Medicine 57(10), 1599–1606 (2016).
[Crossref]
Y. Zhang, C. Zhang, X. Zhong, and D. Zhu, “Quantitative evaluation of SOCS-induced optical clearing efficiency of skull,” Quant. Imaging Med. Surg. 5, 136–142 (2015).
[Crossref]
Y. Zhang, C. Zhang, X. Zhong, and D. Zhu, “Quantitative evaluation of SOCS-induced optical clearing efficiency of skull,” Quant. Imaging Med. Surg. 5, 136–142 (2015).
[Crossref]
Z. Chen, B. Mc Larney, J. Rebling, X. L. Deán-Ben, Q. Zhou, S. Gottschalk, and D. Razansky, “High-Speed Large-Field Multifocal Illumination Fluorescence Microscopy,” Laser Photonics Rev. 14, 1900070 (2020).
[Crossref]
R. Ni, Z. Chen, G. Shi, A. Villois, Q. Zhou, P. Arosio, R. M. Nitsch, P. R. Nilsson, J. Klohs, and D. Razansky, “Transcranial in vivo detection of Aβ at single plaque resolution with large-field multifocal illumination fluorescence microscopy,” bioRxiv, 2020.2002.2001.929844 (2020).
Y. Zhang, C. Zhang, X. Zhong, and D. Zhu, “Quantitative evaluation of SOCS-induced optical clearing efficiency of skull,” Quant. Imaging Med. Surg. 5, 136–142 (2015).
[Crossref]